Organ failure needs the transplanting of functional organs from donors to treat patients. The development of organ preservation solutions enhanced transplantation methodology over time. Ischemia occurs when organs are stored in preservation solutions, resulting in a lack of oxygen and nutrition, which damages the tissues. When the organ is ready for transplantation, reperfusion promotes tissue damage by increasing oxidative stress, endoplasmic reticulum stress, and inflammation. The success of transplanting is decreasing. The inclusion of a proteasome inhibitor in the preservation solution, on the other hand, reduced the damage caused by the ischemia-reperfusion process. The proteasome is a protein structure that regulates inflammation and aids in the removal of damaged proteins. The purpose of this review is to outline the proteasome’s involvement in protecting organs from ischemia-reperfusion injury, as well as the pharmaceutical substances that regulate the proteasome. The success of transplanting is decreasing. The inclusion of a proteasome inhibitor in the preservation solution, on the other hand, reduced the damage caused by the ischemia-reperfusion process. The proteasome is a protein structure that regulates inflammation and aids in the removal of damaged proteins. The purpose of this review is to outline the proteasome’s involvement in protecting organs from ischemia-reperfusion injury, as well as the pharmaceutical substances that regulate the proteasome.
Author (s) Details
Joan Oliva
Clinical Research Department, Emmaus Medical, Torrance, CA 90503, USA.
View Book :- https://stm.bookpi.org/RRAB-V10/article/view/2136
